华尔泰:2022年归母净利润同比下滑47.12%,拟10派1元,苯二胺、环己胺项目计划上半年建成投产
华尔泰3月19日公告,2022年,公司实现营业收入21.01亿元,同比上涨10.97%;归母净利润2.2亿元,同比下滑47.12%;基本每股收益0.66元。本次拟向全体股东每10股派发现金红利1元(含税)。
截至目前,吗啉项目和热电联产项目已经投产;苯二胺、环己胺项目已进入扫尾攻坚阶段,计划于2023 年上半年建成投产;合成氨升级改造项目进入主体工程施工阶段,公司将加快项目建设进度,争取早日建成投产。
Statement:
The content of this article does not represent the views of fxgecko website. The content is for reference only and does not constitute investment suggestions. Investment is risky, so you should be careful in your choice! If it involves content, copyright and other issues, please contact us and we will make adjustments at the first time!